Outcome and Prospective Factor Analysis of High-dose Therapy Combined with Autologous Peripheral Blood Stem Cell Transplantation in Patients with Peripheral T-cell Lymphomas Article Swipe
Meng Wu
,
Xiaopei Wang
,
Yan Xie
,
Weiping Liu
,
Chen Zhang
,
Lingyan Ping
,
Zhitao Ying
,
Lijuan Deng
,
Wen Zheng
,
Ningjing Lin
,
Meifeng Tu
,
Yuqin Song
,
Jun Zhu
·
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.7150/ijms.23067
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.7150/ijms.23067
Background: For peripheral T-cell lymphomas (PTCLs) patients, high-dose therapy combined with autologous peripheral blood stem cell transplantation (HDT/ASCT) has been an alternative treatment option, due to the lack of efficacy from conventional chemotherapy. While not all PTCLs could have benefit in survival from HDT/ASCT. The aim of this study was to evaluate the value of high-dose therapy combined with autologous peripheral blood stem cell transplantation (HDT/ASCT) in Chinese patients with Peripheral T-cell Lymphomas (PTCLs), in order to determine the cohort most suitable to receive HDT/ASCT. Methods: A total of 79 patients with PTCLs who received HDT/ASCT in Peking University Cancer Hospital & Institute from January 2001 to august 2016 were retrospectively analyzed. Results: At a median follow-up time of 23.6 months, the 2-year progression-free survival (PFS) and 2-year overall survival (OS) of the entire cohort were 75.2% and 83.6% respectively. Patients with first complete remission (CR1) (2-year PFS 85.8%, 2-year OS 94.2%) were superior to others in survival. Patients with second complete remission (CR2) had no advantage in survival compared with those with first partial remission (PR1) (2-year PFS: 43.8% vs. 76.2%, p=0.128; 2-year OS: 72.9% vs. 77.1%, p=0.842). In multivariate analysis, response before HDT/ASCT (p=0.001) and LDH before HDT/ASCT (p=0.047) were highly predictive for PFS, while no factors could independently predict OS. Subgroup analysis revealed that HDT/ASCT could improve the survival of patients with angioimmunoblastic T-cell lymphoma (AITL), especially in patients with chemosensitivity. Patients with natural killer / T-cell lymphoma (NKTCL) who received HDT/ASCT with CR1 also had benefit in survival from HDT/ASCT, while nearly 90% of non-CR1 patients appeared bone marrow involvement after HDT/ASCT. Conclusion: Patients who achieved complete remission after first-line therapy, especially with AITL and NKTCL, should strongly be recommended to receive HDT/ASCT. The future prospective trial is warranted.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.7150/ijms.23067
- http://www.medsci.org/v15p0867.pdf
- OA Status
- gold
- Cited By
- 19
- References
- 31
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2808526841
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2808526841Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.7150/ijms.23067Digital Object Identifier
- Title
-
Outcome and Prospective Factor Analysis of High-dose Therapy Combined with Autologous Peripheral Blood Stem Cell Transplantation in Patients with Peripheral T-cell LymphomasWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2018Year of publication
- Publication date
-
2018-01-01Full publication date if available
- Authors
-
Meng Wu, Xiaopei Wang, Yan Xie, Weiping Liu, Chen Zhang, Lingyan Ping, Zhitao Ying, Lijuan Deng, Wen Zheng, Ningjing Lin, Meifeng Tu, Yuqin Song, Jun ZhuList of authors in order
- Landing page
-
https://doi.org/10.7150/ijms.23067Publisher landing page
- PDF URL
-
https://www.medsci.org/v15p0867.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.medsci.org/v15p0867.pdfDirect OA link when available
- Concepts
-
Medicine, Autologous stem-cell transplantation, Internal medicine, Oncology, Transplantation, Peripheral T-cell lymphoma, Lymphoma, Progression-free survival, Cohort, Surgery, Chemotherapy, Gastroenterology, Immunology, T cell, Immune systemTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
19Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1, 2024: 1, 2023: 4, 2022: 2, 2021: 8Per-year citation counts (last 5 years)
- References (count)
-
31Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2808526841 |
|---|---|
| doi | https://doi.org/10.7150/ijms.23067 |
| ids.doi | https://doi.org/10.7150/ijms.23067 |
| ids.mag | 2808526841 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/30008598 |
| ids.openalex | https://openalex.org/W2808526841 |
| fwci | 3.85627617 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000293 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Adolescent |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D000328 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Adult |
| mesh[2].qualifier_ui | Q000627 |
| mesh[2].descriptor_ui | D000971 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | therapeutic use |
| mesh[2].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D002648 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Child |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D003131 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Combined Modality Therapy |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D018572 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Disease-Free Survival |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D005163 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Factor Analysis, Statistical |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D005260 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Female |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D018380 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Hematopoietic Stem Cell Transplantation |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D006801 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Humans |
| mesh[10].qualifier_ui | Q000628 |
| mesh[10].descriptor_ui | D016411 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | therapy |
| mesh[10].descriptor_name | Lymphoma, T-Cell, Peripheral |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D008297 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Male |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D008875 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Middle Aged |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D036102 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Peripheral Blood Stem Cell Transplantation |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D011446 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Prospective Studies |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D012189 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Retrospective Studies |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D014182 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Transplantation, Autologous |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D016896 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Treatment Outcome |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D055815 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Young Adult |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D000293 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Adolescent |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D000328 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Adult |
| mesh[21].qualifier_ui | Q000627 |
| mesh[21].descriptor_ui | D000971 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | therapeutic use |
| mesh[21].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D002648 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Child |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D003131 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Combined Modality Therapy |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D018572 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Disease-Free Survival |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D005163 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Factor Analysis, Statistical |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D005260 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Female |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D018380 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Hematopoietic Stem Cell Transplantation |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D006801 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Humans |
| mesh[29].qualifier_ui | Q000628 |
| mesh[29].descriptor_ui | D016411 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | therapy |
| mesh[29].descriptor_name | Lymphoma, T-Cell, Peripheral |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D008297 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Male |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D008875 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Middle Aged |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D036102 |
| mesh[32].is_major_topic | True |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Peripheral Blood Stem Cell Transplantation |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D011446 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Prospective Studies |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D012189 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Retrospective Studies |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D014182 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Transplantation, Autologous |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D016896 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Treatment Outcome |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D055815 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Young Adult |
| type | article |
| title | Outcome and Prospective Factor Analysis of High-dose Therapy Combined with Autologous Peripheral Blood Stem Cell Transplantation in Patients with Peripheral T-cell Lymphomas |
| biblio.issue | 9 |
| biblio.volume | 15 |
| biblio.last_page | 874 |
| biblio.first_page | 867 |
| topics[0].id | https://openalex.org/T10185 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2734 |
| topics[0].subfield.display_name | Pathology and Forensic Medicine |
| topics[0].display_name | Lymphoma Diagnosis and Treatment |
| topics[1].id | https://openalex.org/T12159 |
| topics[1].field.id | https://openalex.org/fields/24 |
| topics[1].field.display_name | Immunology and Microbiology |
| topics[1].score | 0.9997000098228455 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2403 |
| topics[1].subfield.display_name | Immunology |
| topics[1].display_name | T-cell and Retrovirus Studies |
| topics[2].id | https://openalex.org/T10685 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9983000159263611 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | Viral-associated cancers and disorders |
| is_xpac | False |
| apc_list.value | 2000 |
| apc_list.currency | AUD |
| apc_list.value_usd | 1337 |
| apc_paid.value | 2000 |
| apc_paid.currency | AUD |
| apc_paid.value_usd | 1337 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8412680625915527 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2779050716 |
| concepts[1].level | 3 |
| concepts[1].score | 0.8066709041595459 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q4826373 |
| concepts[1].display_name | Autologous stem-cell transplantation |
| concepts[2].id | https://openalex.org/C126322002 |
| concepts[2].level | 1 |
| concepts[2].score | 0.6527182459831238 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[2].display_name | Internal medicine |
| concepts[3].id | https://openalex.org/C143998085 |
| concepts[3].level | 1 |
| concepts[3].score | 0.5754605531692505 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[3].display_name | Oncology |
| concepts[4].id | https://openalex.org/C2911091166 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5076371431350708 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q106419912 |
| concepts[4].display_name | Transplantation |
| concepts[5].id | https://openalex.org/C2777891184 |
| concepts[5].level | 4 |
| concepts[5].score | 0.48736339807510376 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q7168693 |
| concepts[5].display_name | Peripheral T-cell lymphoma |
| concepts[6].id | https://openalex.org/C2779338263 |
| concepts[6].level | 2 |
| concepts[6].score | 0.46670886874198914 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q208414 |
| concepts[6].display_name | Lymphoma |
| concepts[7].id | https://openalex.org/C2780739268 |
| concepts[7].level | 3 |
| concepts[7].score | 0.43729472160339355 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q2112244 |
| concepts[7].display_name | Progression-free survival |
| concepts[8].id | https://openalex.org/C72563966 |
| concepts[8].level | 2 |
| concepts[8].score | 0.428110808134079 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q1303415 |
| concepts[8].display_name | Cohort |
| concepts[9].id | https://openalex.org/C141071460 |
| concepts[9].level | 1 |
| concepts[9].score | 0.3728213906288147 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q40821 |
| concepts[9].display_name | Surgery |
| concepts[10].id | https://openalex.org/C2776694085 |
| concepts[10].level | 2 |
| concepts[10].score | 0.369259774684906 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q974135 |
| concepts[10].display_name | Chemotherapy |
| concepts[11].id | https://openalex.org/C90924648 |
| concepts[11].level | 1 |
| concepts[11].score | 0.3678613305091858 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q120569 |
| concepts[11].display_name | Gastroenterology |
| concepts[12].id | https://openalex.org/C203014093 |
| concepts[12].level | 1 |
| concepts[12].score | 0.13113003969192505 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[12].display_name | Immunology |
| concepts[13].id | https://openalex.org/C2776090121 |
| concepts[13].level | 3 |
| concepts[13].score | 0.11029374599456787 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q193529 |
| concepts[13].display_name | T cell |
| concepts[14].id | https://openalex.org/C8891405 |
| concepts[14].level | 2 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[14].display_name | Immune system |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8412680625915527 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/autologous-stem-cell-transplantation |
| keywords[1].score | 0.8066709041595459 |
| keywords[1].display_name | Autologous stem-cell transplantation |
| keywords[2].id | https://openalex.org/keywords/internal-medicine |
| keywords[2].score | 0.6527182459831238 |
| keywords[2].display_name | Internal medicine |
| keywords[3].id | https://openalex.org/keywords/oncology |
| keywords[3].score | 0.5754605531692505 |
| keywords[3].display_name | Oncology |
| keywords[4].id | https://openalex.org/keywords/transplantation |
| keywords[4].score | 0.5076371431350708 |
| keywords[4].display_name | Transplantation |
| keywords[5].id | https://openalex.org/keywords/peripheral-t-cell-lymphoma |
| keywords[5].score | 0.48736339807510376 |
| keywords[5].display_name | Peripheral T-cell lymphoma |
| keywords[6].id | https://openalex.org/keywords/lymphoma |
| keywords[6].score | 0.46670886874198914 |
| keywords[6].display_name | Lymphoma |
| keywords[7].id | https://openalex.org/keywords/progression-free-survival |
| keywords[7].score | 0.43729472160339355 |
| keywords[7].display_name | Progression-free survival |
| keywords[8].id | https://openalex.org/keywords/cohort |
| keywords[8].score | 0.428110808134079 |
| keywords[8].display_name | Cohort |
| keywords[9].id | https://openalex.org/keywords/surgery |
| keywords[9].score | 0.3728213906288147 |
| keywords[9].display_name | Surgery |
| keywords[10].id | https://openalex.org/keywords/chemotherapy |
| keywords[10].score | 0.369259774684906 |
| keywords[10].display_name | Chemotherapy |
| keywords[11].id | https://openalex.org/keywords/gastroenterology |
| keywords[11].score | 0.3678613305091858 |
| keywords[11].display_name | Gastroenterology |
| keywords[12].id | https://openalex.org/keywords/immunology |
| keywords[12].score | 0.13113003969192505 |
| keywords[12].display_name | Immunology |
| keywords[13].id | https://openalex.org/keywords/t-cell |
| keywords[13].score | 0.11029374599456787 |
| keywords[13].display_name | T cell |
| language | en |
| locations[0].id | doi:10.7150/ijms.23067 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S46225466 |
| locations[0].source.issn | 1449-1907 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1449-1907 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | International Journal of Medical Sciences |
| locations[0].source.host_organization | https://openalex.org/P4310317973 |
| locations[0].source.host_organization_name | Ivyspring International Publisher |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310317973 |
| locations[0].source.host_organization_lineage_names | Ivyspring International Publisher |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | http://www.medsci.org/v15p0867.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | International Journal of Medical Sciences |
| locations[0].landing_page_url | https://doi.org/10.7150/ijms.23067 |
| locations[1].id | pmid:30008598 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | International journal of medical sciences |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/30008598 |
| locations[2].id | pmh:oai:europepmc.org:4997984 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306400806 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Europe PMC (PubMed Central) |
| locations[2].source.host_organization | https://openalex.org/I1303153112 |
| locations[2].source.host_organization_name | European Bioinformatics Institute |
| locations[2].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/6036090 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5102946858 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Meng Wu |
| authorships[0].countries | CN, ET |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210161752 |
| authorships[0].affiliations[0].raw_affiliation_string | No 52, Fucheng Road, Haidian District, Beijing, China. 100142 |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I4210147617 |
| authorships[0].affiliations[1].raw_affiliation_string | Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute |
| authorships[0].institutions[0].id | https://openalex.org/I4210161752 |
| authorships[0].institutions[0].ror | https://ror.org/058x5eq06 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210161752 |
| authorships[0].institutions[0].country_code | CN |
| authorships[0].institutions[0].display_name | Beijing Haidian Hospital |
| authorships[0].institutions[1].id | https://openalex.org/I4210147617 |
| authorships[0].institutions[1].ror | https://ror.org/0429te836 |
| authorships[0].institutions[1].type | government |
| authorships[0].institutions[1].lineage | https://openalex.org/I4210147617 |
| authorships[0].institutions[1].country_code | ET |
| authorships[0].institutions[1].display_name | Ministry of Education |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Meng Wu |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, No 52, Fucheng Road, Haidian District, Beijing, China. 100142 |
| authorships[1].author.id | https://openalex.org/A5101751677 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-3794-1122 |
| authorships[1].author.display_name | Xiaopei Wang |
| authorships[1].countries | CN, ET |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210147617 |
| authorships[1].affiliations[0].raw_affiliation_string | Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I4210161752 |
| authorships[1].affiliations[1].raw_affiliation_string | No 52, Fucheng Road, Haidian District, Beijing, China. 100142 |
| authorships[1].institutions[0].id | https://openalex.org/I4210161752 |
| authorships[1].institutions[0].ror | https://ror.org/058x5eq06 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210161752 |
| authorships[1].institutions[0].country_code | CN |
| authorships[1].institutions[0].display_name | Beijing Haidian Hospital |
| authorships[1].institutions[1].id | https://openalex.org/I4210147617 |
| authorships[1].institutions[1].ror | https://ror.org/0429te836 |
| authorships[1].institutions[1].type | government |
| authorships[1].institutions[1].lineage | https://openalex.org/I4210147617 |
| authorships[1].institutions[1].country_code | ET |
| authorships[1].institutions[1].display_name | Ministry of Education |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Xiaopei Wang |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, No 52, Fucheng Road, Haidian District, Beijing, China. 100142 |
| authorships[2].author.id | https://openalex.org/A5101927248 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-9352-596X |
| authorships[2].author.display_name | Yan Xie |
| authorships[2].countries | CN, ET |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210161752 |
| authorships[2].affiliations[0].raw_affiliation_string | No 52, Fucheng Road, Haidian District, Beijing, China. 100142 |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I4210147617 |
| authorships[2].affiliations[1].raw_affiliation_string | Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute |
| authorships[2].institutions[0].id | https://openalex.org/I4210161752 |
| authorships[2].institutions[0].ror | https://ror.org/058x5eq06 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210161752 |
| authorships[2].institutions[0].country_code | CN |
| authorships[2].institutions[0].display_name | Beijing Haidian Hospital |
| authorships[2].institutions[1].id | https://openalex.org/I4210147617 |
| authorships[2].institutions[1].ror | https://ror.org/0429te836 |
| authorships[2].institutions[1].type | government |
| authorships[2].institutions[1].lineage | https://openalex.org/I4210147617 |
| authorships[2].institutions[1].country_code | ET |
| authorships[2].institutions[1].display_name | Ministry of Education |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Yan Xie |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, No 52, Fucheng Road, Haidian District, Beijing, China. 100142 |
| authorships[3].author.id | https://openalex.org/A5100355614 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-0367-1411 |
| authorships[3].author.display_name | Weiping Liu |
| authorships[3].countries | CN, ET |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210161752 |
| authorships[3].affiliations[0].raw_affiliation_string | No 52, Fucheng Road, Haidian District, Beijing, China. 100142 |
| authorships[3].affiliations[1].institution_ids | https://openalex.org/I4210147617 |
| authorships[3].affiliations[1].raw_affiliation_string | Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute |
| authorships[3].institutions[0].id | https://openalex.org/I4210161752 |
| authorships[3].institutions[0].ror | https://ror.org/058x5eq06 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210161752 |
| authorships[3].institutions[0].country_code | CN |
| authorships[3].institutions[0].display_name | Beijing Haidian Hospital |
| authorships[3].institutions[1].id | https://openalex.org/I4210147617 |
| authorships[3].institutions[1].ror | https://ror.org/0429te836 |
| authorships[3].institutions[1].type | government |
| authorships[3].institutions[1].lineage | https://openalex.org/I4210147617 |
| authorships[3].institutions[1].country_code | ET |
| authorships[3].institutions[1].display_name | Ministry of Education |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Weiping Liu |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, No 52, Fucheng Road, Haidian District, Beijing, China. 100142 |
| authorships[4].author.id | https://openalex.org/A5100374152 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-9461-1755 |
| authorships[4].author.display_name | Chen Zhang |
| authorships[4].countries | CN, ET |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210161752 |
| authorships[4].affiliations[0].raw_affiliation_string | No 52, Fucheng Road, Haidian District, Beijing, China. 100142 |
| authorships[4].affiliations[1].institution_ids | https://openalex.org/I4210147617 |
| authorships[4].affiliations[1].raw_affiliation_string | Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute |
| authorships[4].institutions[0].id | https://openalex.org/I4210161752 |
| authorships[4].institutions[0].ror | https://ror.org/058x5eq06 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210161752 |
| authorships[4].institutions[0].country_code | CN |
| authorships[4].institutions[0].display_name | Beijing Haidian Hospital |
| authorships[4].institutions[1].id | https://openalex.org/I4210147617 |
| authorships[4].institutions[1].ror | https://ror.org/0429te836 |
| authorships[4].institutions[1].type | government |
| authorships[4].institutions[1].lineage | https://openalex.org/I4210147617 |
| authorships[4].institutions[1].country_code | ET |
| authorships[4].institutions[1].display_name | Ministry of Education |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Chen Zhang |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, No 52, Fucheng Road, Haidian District, Beijing, China. 100142 |
| authorships[5].author.id | https://openalex.org/A5061482899 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Lingyan Ping |
| authorships[5].countries | CN, ET |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210161752 |
| authorships[5].affiliations[0].raw_affiliation_string | No 52, Fucheng Road, Haidian District, Beijing, China. 100142 |
| authorships[5].affiliations[1].institution_ids | https://openalex.org/I4210147617 |
| authorships[5].affiliations[1].raw_affiliation_string | Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute |
| authorships[5].institutions[0].id | https://openalex.org/I4210161752 |
| authorships[5].institutions[0].ror | https://ror.org/058x5eq06 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210161752 |
| authorships[5].institutions[0].country_code | CN |
| authorships[5].institutions[0].display_name | Beijing Haidian Hospital |
| authorships[5].institutions[1].id | https://openalex.org/I4210147617 |
| authorships[5].institutions[1].ror | https://ror.org/0429te836 |
| authorships[5].institutions[1].type | government |
| authorships[5].institutions[1].lineage | https://openalex.org/I4210147617 |
| authorships[5].institutions[1].country_code | ET |
| authorships[5].institutions[1].display_name | Ministry of Education |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Lingyan Ping |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, No 52, Fucheng Road, Haidian District, Beijing, China. 100142 |
| authorships[6].author.id | https://openalex.org/A5028076162 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-9794-7190 |
| authorships[6].author.display_name | Zhitao Ying |
| authorships[6].countries | CN, ET |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210161752 |
| authorships[6].affiliations[0].raw_affiliation_string | No 52, Fucheng Road, Haidian District, Beijing, China. 100142 |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I4210147617 |
| authorships[6].affiliations[1].raw_affiliation_string | Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute |
| authorships[6].institutions[0].id | https://openalex.org/I4210161752 |
| authorships[6].institutions[0].ror | https://ror.org/058x5eq06 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210161752 |
| authorships[6].institutions[0].country_code | CN |
| authorships[6].institutions[0].display_name | Beijing Haidian Hospital |
| authorships[6].institutions[1].id | https://openalex.org/I4210147617 |
| authorships[6].institutions[1].ror | https://ror.org/0429te836 |
| authorships[6].institutions[1].type | government |
| authorships[6].institutions[1].lineage | https://openalex.org/I4210147617 |
| authorships[6].institutions[1].country_code | ET |
| authorships[6].institutions[1].display_name | Ministry of Education |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Zhitao Ying |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, No 52, Fucheng Road, Haidian District, Beijing, China. 100142 |
| authorships[7].author.id | https://openalex.org/A5101428089 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-5072-390X |
| authorships[7].author.display_name | Lijuan Deng |
| authorships[7].countries | CN, ET |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210147617 |
| authorships[7].affiliations[0].raw_affiliation_string | Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute |
| authorships[7].affiliations[1].institution_ids | https://openalex.org/I4210161752 |
| authorships[7].affiliations[1].raw_affiliation_string | No 52, Fucheng Road, Haidian District, Beijing, China. 100142 |
| authorships[7].institutions[0].id | https://openalex.org/I4210161752 |
| authorships[7].institutions[0].ror | https://ror.org/058x5eq06 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210161752 |
| authorships[7].institutions[0].country_code | CN |
| authorships[7].institutions[0].display_name | Beijing Haidian Hospital |
| authorships[7].institutions[1].id | https://openalex.org/I4210147617 |
| authorships[7].institutions[1].ror | https://ror.org/0429te836 |
| authorships[7].institutions[1].type | government |
| authorships[7].institutions[1].lineage | https://openalex.org/I4210147617 |
| authorships[7].institutions[1].country_code | ET |
| authorships[7].institutions[1].display_name | Ministry of Education |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Lijuan Deng |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, No 52, Fucheng Road, Haidian District, Beijing, China. 100142 |
| authorships[8].author.id | https://openalex.org/A5101966924 |
| authorships[8].author.orcid | https://orcid.org/0009-0002-8932-4564 |
| authorships[8].author.display_name | Wen Zheng |
| authorships[8].countries | CN, ET |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210147617 |
| authorships[8].affiliations[0].raw_affiliation_string | Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute |
| authorships[8].affiliations[1].institution_ids | https://openalex.org/I4210161752 |
| authorships[8].affiliations[1].raw_affiliation_string | No 52, Fucheng Road, Haidian District, Beijing, China. 100142 |
| authorships[8].institutions[0].id | https://openalex.org/I4210161752 |
| authorships[8].institutions[0].ror | https://ror.org/058x5eq06 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210161752 |
| authorships[8].institutions[0].country_code | CN |
| authorships[8].institutions[0].display_name | Beijing Haidian Hospital |
| authorships[8].institutions[1].id | https://openalex.org/I4210147617 |
| authorships[8].institutions[1].ror | https://ror.org/0429te836 |
| authorships[8].institutions[1].type | government |
| authorships[8].institutions[1].lineage | https://openalex.org/I4210147617 |
| authorships[8].institutions[1].country_code | ET |
| authorships[8].institutions[1].display_name | Ministry of Education |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Wen Zheng |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, No 52, Fucheng Road, Haidian District, Beijing, China. 100142 |
| authorships[9].author.id | https://openalex.org/A5109129506 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Ningjing Lin |
| authorships[9].countries | CN, ET |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210161752 |
| authorships[9].affiliations[0].raw_affiliation_string | No 52, Fucheng Road, Haidian District, Beijing, China. 100142 |
| authorships[9].affiliations[1].institution_ids | https://openalex.org/I4210147617 |
| authorships[9].affiliations[1].raw_affiliation_string | Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute |
| authorships[9].institutions[0].id | https://openalex.org/I4210161752 |
| authorships[9].institutions[0].ror | https://ror.org/058x5eq06 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210161752 |
| authorships[9].institutions[0].country_code | CN |
| authorships[9].institutions[0].display_name | Beijing Haidian Hospital |
| authorships[9].institutions[1].id | https://openalex.org/I4210147617 |
| authorships[9].institutions[1].ror | https://ror.org/0429te836 |
| authorships[9].institutions[1].type | government |
| authorships[9].institutions[1].lineage | https://openalex.org/I4210147617 |
| authorships[9].institutions[1].country_code | ET |
| authorships[9].institutions[1].display_name | Ministry of Education |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Ningjing Lin |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, No 52, Fucheng Road, Haidian District, Beijing, China. 100142 |
| authorships[10].author.id | https://openalex.org/A5109700816 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Meifeng Tu |
| authorships[10].countries | CN, ET |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210147617 |
| authorships[10].affiliations[0].raw_affiliation_string | Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute |
| authorships[10].affiliations[1].institution_ids | https://openalex.org/I4210161752 |
| authorships[10].affiliations[1].raw_affiliation_string | No 52, Fucheng Road, Haidian District, Beijing, China. 100142 |
| authorships[10].institutions[0].id | https://openalex.org/I4210161752 |
| authorships[10].institutions[0].ror | https://ror.org/058x5eq06 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210161752 |
| authorships[10].institutions[0].country_code | CN |
| authorships[10].institutions[0].display_name | Beijing Haidian Hospital |
| authorships[10].institutions[1].id | https://openalex.org/I4210147617 |
| authorships[10].institutions[1].ror | https://ror.org/0429te836 |
| authorships[10].institutions[1].type | government |
| authorships[10].institutions[1].lineage | https://openalex.org/I4210147617 |
| authorships[10].institutions[1].country_code | ET |
| authorships[10].institutions[1].display_name | Ministry of Education |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Meifeng Tu |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, No 52, Fucheng Road, Haidian District, Beijing, China. 100142 |
| authorships[11].author.id | https://openalex.org/A5037498466 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-5451-6481 |
| authorships[11].author.display_name | Yuqin Song |
| authorships[11].countries | CN, ET |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210161752 |
| authorships[11].affiliations[0].raw_affiliation_string | No 52, Fucheng Road, Haidian District, Beijing, China. 100142 |
| authorships[11].affiliations[1].institution_ids | https://openalex.org/I4210147617 |
| authorships[11].affiliations[1].raw_affiliation_string | Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute |
| authorships[11].institutions[0].id | https://openalex.org/I4210161752 |
| authorships[11].institutions[0].ror | https://ror.org/058x5eq06 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210161752 |
| authorships[11].institutions[0].country_code | CN |
| authorships[11].institutions[0].display_name | Beijing Haidian Hospital |
| authorships[11].institutions[1].id | https://openalex.org/I4210147617 |
| authorships[11].institutions[1].ror | https://ror.org/0429te836 |
| authorships[11].institutions[1].type | government |
| authorships[11].institutions[1].lineage | https://openalex.org/I4210147617 |
| authorships[11].institutions[1].country_code | ET |
| authorships[11].institutions[1].display_name | Ministry of Education |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Yuqin Song |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, No 52, Fucheng Road, Haidian District, Beijing, China. 100142 |
| authorships[12].author.id | https://openalex.org/A5030040961 |
| authorships[12].author.orcid | https://orcid.org/0000-0003-3479-2547 |
| authorships[12].author.display_name | Jun Zhu |
| authorships[12].countries | CN, ET |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210147617 |
| authorships[12].affiliations[0].raw_affiliation_string | Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute |
| authorships[12].affiliations[1].institution_ids | https://openalex.org/I4210161752 |
| authorships[12].affiliations[1].raw_affiliation_string | No 52, Fucheng Road, Haidian District, Beijing, China. 100142 |
| authorships[12].institutions[0].id | https://openalex.org/I4210161752 |
| authorships[12].institutions[0].ror | https://ror.org/058x5eq06 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I4210161752 |
| authorships[12].institutions[0].country_code | CN |
| authorships[12].institutions[0].display_name | Beijing Haidian Hospital |
| authorships[12].institutions[1].id | https://openalex.org/I4210147617 |
| authorships[12].institutions[1].ror | https://ror.org/0429te836 |
| authorships[12].institutions[1].type | government |
| authorships[12].institutions[1].lineage | https://openalex.org/I4210147617 |
| authorships[12].institutions[1].country_code | ET |
| authorships[12].institutions[1].display_name | Ministry of Education |
| authorships[12].author_position | last |
| authorships[12].raw_author_name | Jun Zhu |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, No 52, Fucheng Road, Haidian District, Beijing, China. 100142 |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | http://www.medsci.org/v15p0867.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Outcome and Prospective Factor Analysis of High-dose Therapy Combined with Autologous Peripheral Blood Stem Cell Transplantation in Patients with Peripheral T-cell Lymphomas |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10185 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2734 |
| primary_topic.subfield.display_name | Pathology and Forensic Medicine |
| primary_topic.display_name | Lymphoma Diagnosis and Treatment |
| related_works | https://openalex.org/W3032246833, https://openalex.org/W2412306442, https://openalex.org/W2065582169, https://openalex.org/W2937428028, https://openalex.org/W2352815992, https://openalex.org/W1992594661, https://openalex.org/W2594642741, https://openalex.org/W2412435376, https://openalex.org/W2006193743, https://openalex.org/W2307739936 |
| cited_by_count | 19 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 1 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 4 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 2 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 8 |
| counts_by_year[5].year | 2020 |
| counts_by_year[5].cited_by_count | 3 |
| locations_count | 3 |
| best_oa_location.id | doi:10.7150/ijms.23067 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S46225466 |
| best_oa_location.source.issn | 1449-1907 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1449-1907 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | International Journal of Medical Sciences |
| best_oa_location.source.host_organization | https://openalex.org/P4310317973 |
| best_oa_location.source.host_organization_name | Ivyspring International Publisher |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310317973 |
| best_oa_location.source.host_organization_lineage_names | Ivyspring International Publisher |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | http://www.medsci.org/v15p0867.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | International Journal of Medical Sciences |
| best_oa_location.landing_page_url | https://doi.org/10.7150/ijms.23067 |
| primary_location.id | doi:10.7150/ijms.23067 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S46225466 |
| primary_location.source.issn | 1449-1907 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1449-1907 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | International Journal of Medical Sciences |
| primary_location.source.host_organization | https://openalex.org/P4310317973 |
| primary_location.source.host_organization_name | Ivyspring International Publisher |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310317973 |
| primary_location.source.host_organization_lineage_names | Ivyspring International Publisher |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | http://www.medsci.org/v15p0867.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | International Journal of Medical Sciences |
| primary_location.landing_page_url | https://doi.org/10.7150/ijms.23067 |
| publication_date | 2018-01-01 |
| publication_year | 2018 |
| referenced_works | https://openalex.org/W2264394109, https://openalex.org/W2206063761, https://openalex.org/W6679740444, https://openalex.org/W2766489122, https://openalex.org/W2038035645, https://openalex.org/W2088191368, https://openalex.org/W2145164152, https://openalex.org/W2162389158, https://openalex.org/W2098666639, https://openalex.org/W2055952037, https://openalex.org/W2060840793, https://openalex.org/W2071711915, https://openalex.org/W2054319900, https://openalex.org/W2131745105, https://openalex.org/W2079965252, https://openalex.org/W6978996086, https://openalex.org/W2131587457, https://openalex.org/W2144342588, https://openalex.org/W2026574548, https://openalex.org/W2098436895, https://openalex.org/W2102908194, https://openalex.org/W1571669741, https://openalex.org/W2606016578, https://openalex.org/W4248290240, https://openalex.org/W2338801032, https://openalex.org/W2416844197, https://openalex.org/W2015684600, https://openalex.org/W2133201432, https://openalex.org/W2503110302, https://openalex.org/W4239436002, https://openalex.org/W2076257589 |
| referenced_works_count | 31 |
| abstract_inverted_index.& | 101 |
| abstract_inverted_index./ | 238 |
| abstract_inverted_index.A | 86 |
| abstract_inverted_index.a | 114 |
| abstract_inverted_index.79 | 89 |
| abstract_inverted_index.At | 113 |
| abstract_inverted_index.In | 189 |
| abstract_inverted_index.OS | 150 |
| abstract_inverted_index.an | 20 |
| abstract_inverted_index.be | 282 |
| abstract_inverted_index.in | 40, 66, 74, 96, 156, 167, 230, 250 |
| abstract_inverted_index.is | 291 |
| abstract_inverted_index.no | 165, 207 |
| abstract_inverted_index.of | 28, 46, 54, 88, 118, 131, 222, 257 |
| abstract_inverted_index.to | 25, 50, 76, 82, 106, 154, 284 |
| abstract_inverted_index.90% | 256 |
| abstract_inverted_index.CR1 | 246 |
| abstract_inverted_index.For | 1 |
| abstract_inverted_index.LDH | 197 |
| abstract_inverted_index.OS. | 212 |
| abstract_inverted_index.OS: | 184 |
| abstract_inverted_index.PFS | 147 |
| abstract_inverted_index.The | 44, 287 |
| abstract_inverted_index.aim | 45 |
| abstract_inverted_index.all | 35 |
| abstract_inverted_index.and | 126, 137, 196, 278 |
| abstract_inverted_index.due | 24 |
| abstract_inverted_index.for | 204 |
| abstract_inverted_index.had | 164, 248 |
| abstract_inverted_index.has | 18 |
| abstract_inverted_index.not | 34 |
| abstract_inverted_index.the | 26, 52, 78, 121, 132, 220 |
| abstract_inverted_index.was | 49 |
| abstract_inverted_index.who | 93, 242, 268 |
| abstract_inverted_index.(OS) | 130 |
| abstract_inverted_index.2001 | 105 |
| abstract_inverted_index.2016 | 108 |
| abstract_inverted_index.23.6 | 119 |
| abstract_inverted_index.AITL | 277 |
| abstract_inverted_index.PFS, | 205 |
| abstract_inverted_index.PFS: | 178 |
| abstract_inverted_index.also | 247 |
| abstract_inverted_index.been | 19 |
| abstract_inverted_index.bone | 261 |
| abstract_inverted_index.cell | 15, 63 |
| abstract_inverted_index.from | 30, 42, 103, 252 |
| abstract_inverted_index.have | 38 |
| abstract_inverted_index.lack | 27 |
| abstract_inverted_index.most | 80 |
| abstract_inverted_index.stem | 14, 62 |
| abstract_inverted_index.that | 216 |
| abstract_inverted_index.this | 47 |
| abstract_inverted_index.time | 117 |
| abstract_inverted_index.were | 109, 135, 152, 201 |
| abstract_inverted_index.with | 10, 58, 69, 91, 141, 159, 170, 172, 224, 232, 235, 245, 276 |
| abstract_inverted_index.(CR1) | 145 |
| abstract_inverted_index.(CR2) | 163 |
| abstract_inverted_index.(PFS) | 125 |
| abstract_inverted_index.(PR1) | 176 |
| abstract_inverted_index.43.8% | 179 |
| abstract_inverted_index.72.9% | 185 |
| abstract_inverted_index.75.2% | 136 |
| abstract_inverted_index.83.6% | 138 |
| abstract_inverted_index.PTCLs | 36, 92 |
| abstract_inverted_index.While | 33 |
| abstract_inverted_index.after | 264, 272 |
| abstract_inverted_index.blood | 13, 61 |
| abstract_inverted_index.could | 37, 209, 218 |
| abstract_inverted_index.first | 142, 173 |
| abstract_inverted_index.order | 75 |
| abstract_inverted_index.study | 48 |
| abstract_inverted_index.those | 171 |
| abstract_inverted_index.total | 87 |
| abstract_inverted_index.trial | 290 |
| abstract_inverted_index.value | 53 |
| abstract_inverted_index.while | 206, 254 |
| abstract_inverted_index.2-year | 122, 127, 149, 183 |
| abstract_inverted_index.76.2%, | 181 |
| abstract_inverted_index.77.1%, | 187 |
| abstract_inverted_index.85.8%, | 148 |
| abstract_inverted_index.94.2%) | 151 |
| abstract_inverted_index.Cancer | 99 |
| abstract_inverted_index.NKTCL, | 279 |
| abstract_inverted_index.Peking | 97 |
| abstract_inverted_index.T-cell | 3, 71, 226, 239 |
| abstract_inverted_index.august | 107 |
| abstract_inverted_index.before | 193, 198 |
| abstract_inverted_index.cohort | 79, 134 |
| abstract_inverted_index.entire | 133 |
| abstract_inverted_index.future | 288 |
| abstract_inverted_index.highly | 202 |
| abstract_inverted_index.killer | 237 |
| abstract_inverted_index.marrow | 262 |
| abstract_inverted_index.median | 115 |
| abstract_inverted_index.nearly | 255 |
| abstract_inverted_index.others | 155 |
| abstract_inverted_index.second | 160 |
| abstract_inverted_index.should | 280 |
| abstract_inverted_index.(2-year | 146, 177 |
| abstract_inverted_index.(AITL), | 228 |
| abstract_inverted_index.(NKTCL) | 241 |
| abstract_inverted_index.(PTCLs) | 5 |
| abstract_inverted_index.Chinese | 67 |
| abstract_inverted_index.January | 104 |
| abstract_inverted_index.benefit | 39, 249 |
| abstract_inverted_index.factors | 208 |
| abstract_inverted_index.improve | 219 |
| abstract_inverted_index.months, | 120 |
| abstract_inverted_index.natural | 236 |
| abstract_inverted_index.non-CR1 | 258 |
| abstract_inverted_index.option, | 23 |
| abstract_inverted_index.overall | 128 |
| abstract_inverted_index.partial | 174 |
| abstract_inverted_index.predict | 211 |
| abstract_inverted_index.receive | 83, 285 |
| abstract_inverted_index.therapy | 8, 56 |
| abstract_inverted_index.(PTCLs), | 73 |
| abstract_inverted_index.HDT/ASCT | 95, 194, 199, 217, 244 |
| abstract_inverted_index.Hospital | 100 |
| abstract_inverted_index.Patients | 140, 158, 234, 267 |
| abstract_inverted_index.Subgroup | 213 |
| abstract_inverted_index.achieved | 269 |
| abstract_inverted_index.analysis | 214 |
| abstract_inverted_index.appeared | 260 |
| abstract_inverted_index.combined | 9, 57 |
| abstract_inverted_index.compared | 169 |
| abstract_inverted_index.complete | 143, 161, 270 |
| abstract_inverted_index.efficacy | 29 |
| abstract_inverted_index.evaluate | 51 |
| abstract_inverted_index.lymphoma | 227, 240 |
| abstract_inverted_index.patients | 68, 90, 223, 231, 259 |
| abstract_inverted_index.received | 94, 243 |
| abstract_inverted_index.response | 192 |
| abstract_inverted_index.revealed | 215 |
| abstract_inverted_index.strongly | 281 |
| abstract_inverted_index.suitable | 81 |
| abstract_inverted_index.superior | 153 |
| abstract_inverted_index.survival | 41, 124, 129, 168, 221, 251 |
| abstract_inverted_index.therapy, | 274 |
| abstract_inverted_index.HDT/ASCT, | 253 |
| abstract_inverted_index.HDT/ASCT. | 43, 84, 265, 286 |
| abstract_inverted_index.Institute | 102 |
| abstract_inverted_index.Lymphomas | 72 |
| abstract_inverted_index.advantage | 166 |
| abstract_inverted_index.analysis, | 191 |
| abstract_inverted_index.analyzed. | 111 |
| abstract_inverted_index.determine | 77 |
| abstract_inverted_index.follow-up | 116 |
| abstract_inverted_index.high-dose | 7, 55 |
| abstract_inverted_index.lymphomas | 4 |
| abstract_inverted_index.patients, | 6 |
| abstract_inverted_index.remission | 144, 162, 175, 271 |
| abstract_inverted_index.survival. | 157 |
| abstract_inverted_index.treatment | 22 |
| abstract_inverted_index.(HDT/ASCT) | 17, 65 |
| abstract_inverted_index.<i>vs.</i> | 180, 186 |
| abstract_inverted_index.Peripheral | 70 |
| abstract_inverted_index.University | 98 |
| abstract_inverted_index.autologous | 11, 59 |
| abstract_inverted_index.especially | 229, 275 |
| abstract_inverted_index.first-line | 273 |
| abstract_inverted_index.peripheral | 2, 12, 60 |
| abstract_inverted_index.predictive | 203 |
| abstract_inverted_index.warranted. | 292 |
| abstract_inverted_index.alternative | 21 |
| abstract_inverted_index.involvement | 263 |
| abstract_inverted_index.prospective | 289 |
| abstract_inverted_index.recommended | 283 |
| abstract_inverted_index.conventional | 31 |
| abstract_inverted_index.multivariate | 190 |
| abstract_inverted_index.chemotherapy. | 32 |
| abstract_inverted_index.independently | 210 |
| abstract_inverted_index.respectively. | 139 |
| abstract_inverted_index.<b>Methods:</b> | 85 |
| abstract_inverted_index.<b>Results:</b> | 112 |
| abstract_inverted_index.<i>p</i>=0.128; | 182 |
| abstract_inverted_index.retrospectively | 110 |
| abstract_inverted_index.transplantation | 16, 64 |
| abstract_inverted_index.(<i>p</i>=0.001) | 195 |
| abstract_inverted_index.(<i>p</i>=0.047) | 200 |
| abstract_inverted_index.<i>p</i>=0.842). | 188 |
| abstract_inverted_index.progression-free | 123 |
| abstract_inverted_index.chemosensitivity. | 233 |
| abstract_inverted_index.<b>Background:</b> | 0 |
| abstract_inverted_index.<b>Conclusion:</b> | 266 |
| abstract_inverted_index.angioimmunoblastic | 225 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 90 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 13 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7400000095367432 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.91817401 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |